5.885
Kalaris Therapeutics Inc 주식(KLRS)의 최신 뉴스
Is Kalaris Therapeutics Inc. stock a good choice for value investorsEarnings Beat & Verified High Yield Trade Plans - Newser
Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives $11.50 Consensus Target Price from Brokerages - Defense World
Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
We Think Kalaris Therapeutics (NASDAQ:KLRS) Needs To Drive Business Growth Carefully - Yahoo Finance
What analysts say about Kalaris Therapeutics Inc stockCandlestick Pattern Analysis & Rapid Capital Growth - earlytimes.in
Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference - The Globe and Mail
Kalaris (Nasdaq: KLRS) to present at Noble Capital 21st Emerging Growth Conference - Stock Titan
Kalaris Therapeutics Inc. (KLRS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kalaris Therapeutics, Inc. (KLRS) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What risks investors should watch in Kalaris Therapeutics Inc. stockJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
Equities Analysts Offer Predictions for KLRS Q4 Earnings - Defense World
Kalaris Therapeutics (NASDAQ:KLRS) Is In A Good Position To Deliver On Growth Plans - Sahm
What’s next for Kalaris Therapeutics Inc. stock priceTrade Exit Summary & Trade Opportunity Analysis - newser.com
Will Kalaris Therapeutics Inc. stock benefit from commodity pricesLong Setup & Daily Volume Surge Trade Alerts - newser.com
What MACD and RSI say about Kalaris Therapeutics Inc.2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Can Kalaris Therapeutics Inc. stock deliver surprise earnings beat - newser.com
Can Kalaris Therapeutics Inc. rally from current levelsMarket Growth Summary & Stepwise Trade Execution Plans - newser.com
Kalaris stock rating reiterated at Strong Buy by Raymond James - Investing.com Canada
Kalaris Therapeutics Reports Q3 2025 Financial Progress - MSN
How to use a screener to detect Kalaris Therapeutics Inc. breakoutsWeekly Investment Report & Verified Momentum Watchlists - newser.com
Kalaris Therapeutics (KLRS) Price Target Increased by 10.87% to 17.34 - Nasdaq
Analyzing Kalaris Therapeutics Inc. with risk reward ratio charts2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
Applying sector rotation models to Kalaris Therapeutics Inc.Oil Prices & Technical Confirmation Trade Alerts - newser.com
What to expect from Kalaris Therapeutics Inc. in the next 30 daysMarket Performance Summary & Consistent Profit Trading Strategies - newser.com
Does Kalaris Therapeutics Inc. qualify in momentum factor screeningMarket Rally & AI Driven Price Predictions - newser.com
What is William Blair's Estimate for KLRS FY2025 Earnings? - MarketBeat
William Blair Has Negative Estimate for KLRS FY2025 Earnings - Defense World
Is Kalaris Therapeutics Inc. stock positioned for digital transformationLong Setup & Expert Verified Movement Alerts - newser.com
How resilient is Kalaris Therapeutics Inc. stock in market downturnsWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
Will Kalaris Therapeutics Inc. outperform the marketGap Down & Fast Moving Stock Watchlists - newser.com
자본화:
|
볼륨(24시간):